GlassScriptPhysician profile
Brian T Scully
NPI 1841209368
$1,989.64
in general payments reported to CMS, 2019-2025
17 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $52.24 · 2021: $154 · 2022: $706 · 2023: $249 · 2024: $321 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $548.23 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $420.67 | 2019-2024 | Camzyos, Eliquis |
| Pfizer INC. | $229.84 | 2019-2021 | |
| Shockwave Medical, INC | $220.49 | 2022 | |
| Merit Medical Systems INC | $125.00 | 2025 | Prelude Introducers |
| Boston Scientific Corporation | $107.69 | 2025 | Watchman Access System |
| Astellas Pharma US INC | $98.99 | 2022 | |
| Atricure, INC. | $41.71 | 2024 | |
| Medline Industries LP | $35.25 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.83 | 2022 | |
| Cleerly, INC. | $27.63 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Braemar Manufacturing, LLC | $21.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.53 | 2023 | Farxiga |
| Cook Medical LLC | $17.97 | 2022 | |
| Edwards Lifesciences Corporation | $16.69 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.07 | 2021 | |
| Allergan, INC. | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Scully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.